Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-257-6 | CAS number: 93-55-0
Endpoint summary
Administrative data
Description of key information
Not expected to be skin sensitising
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There are no information about skin sensitisation potential of propiophenone, thus the available data on the structural analogous acetophenone have been taken into account. The Read Across approach can be considered appropriate for the assessement of skin sensitisation. Details can be found in the Read Across justification document attached in section 13 of IUCLID.
Modified Draize test was performed to assess the acetophenone potential to induce allergic contact dermatitis in guinea pigs. For each test material preliminary irritation tests were done in guinea pigs to determine concentrations suitable for sensitization testing. Guinea pigs were then treated by intradermal injection to induce sensitization and challenged 2 weeks later by both intradermal injection and topical application. When there was no evidence of sensitization the induction and challenge procedures were repeated. The Injection challenge concentration was 0.25 %, while the application challenge concentration (ACC) was 20 %. The test item does not shown signs of sensitisation potential (Sharp, 1978).
Furthermore, a maximization test (Kligman, 1966) on acetophenone at 2 % concentration showed no reactions on human subjects (Kligman, 1971).
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
According to the CLP Regulation (EC 1272/2008), 3.4 Respiratory or skin sensitisation section, skin sensitizer means a substance that will lead to an allergic response following skin contact.
Substances shall be classified as skin sensitisers (Category 1):
(a) if there is evidence in humans that the substance can lead to sensitisation by skin contact in a substantial number of persons; or
(b) if there are positive results from an appropriate animal test (e.g. Local lymph node assay, Guinea pig maximisation test, Buehler assay)
On the basis of the available information, the substance is expected to be non skin sensitising.
In conclusion, propiophenone does not meet the criteria to be classified as skin sensitizer, according to the CLP Regulation (EC 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
